Loading...
Bleomycin‐induced pulmonary toxicity and treatment with infliximab: A case report
Given the current understanding of bleomycin‐induced pneumonitis (BIP), the use of tumor necrosis factor alpha (TNF‐α) inhibitors such as infliximab for late‐stage disease appears to be of limited benefit. Further research regarding prevention and management of advanced BIP is required.
Saved in:
| Published in: | Clin Case Rep |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
John Wiley and Sons Inc.
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6186889/ https://ncbi.nlm.nih.gov/pubmed/30349718 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.1790 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|